HeartsciencesHSCS
13F holders, Q4 2024 (December 31)3holders −3
0new positions
3sold out
$3.82avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Heartsciences Inc. (HSCS) in their 13F filings, down 3 from Q3 2024. 0 opened new positions and 3 sold out. The largest holders were UBS Group AG ($5K), Tower Research Capital LLC (TRC) ($382) and Bank of America Corp. ($31).
- Company
- Heartsciences Inc.
- CUSIP
- 42254E302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $49K |
All 13F filers, Q3 2024 → Q4 2024: 625 shares bought and 12,249 shares sold, net −11,624 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| UBS Group AG | 0.00% | Add +91.6% | 1,305 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -94.7% | 100 | $382 |
| Bank of America Corp. | 0.00% | Add +14.3% | 8 | $31 |
"% of holder's portfolio" is HSCS's weight in each manager's 13F, not the share of Heartsciences Inc. the manager owns.